Case Report

Jaundice Secondary to Isolated Porta Hepatis Metastasis in Colorectal Cancer: Case Report and Review of the Literature

Authors: Souad S. Youssef, MD, Pullatikurthi Pradeep Kumar, MD

Abstract

Colorectal cancer occurs mainly after the age of 50. The liver is the most frequent site of metastases, although isolated metastases to the porta hepatis are rarely reported in the literature. From 1924 to 1993, only 16 cases of periportal lymph nodes metastases were reported. We report a case of jaundice secondary to porta hepatis metastases from primary colorectal cancer. The appearance of symptoms was concurrent with the elevation of carcinoembryonic antigen in our case. This emphasizes the importance of polymerase chain reaction to detect the small amount of carcinoembryonic antigen transcript in blood or in peritoneal fluid before the appearance of symptoms. Polymerase chain reaction allows the prediction of high risk of recurrence and the presence of micrometastases. More trials are needed to assess the outcome after treatment by adjuvant chemotherapy for micrometastases.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
 
2. Makela J, Kiviniemi H, Laitinen S. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma. Hepatogastroenterology 2002; 49: 971–975.
 
3. Devesa JM, Morales V, Enriquez JM, et al. Colorectal cancer: The bases for a comprehensive follow-up. Dis Colon Rectum 1988; 31: 636–652.
 
4. Berlin JW, Gore RM, Yaghmai V, et al. Staging of colorectal cancer. Semin Roentgenol 2000; 35: 370–384.
 
5. Olm M, Pera M, Fuster J, et al. Acute severe jaundice in a young patient. Arq Gastroenterol 1990; 27: 204(letter).
 
6. Lo CY, Lai EC. Palliation for extrahepatic biliary obstruction by metastatic colorectal carcinoma. Am J Gastroenterol 1994; 89: 1852–1855.
 
7. Contractor FM, Sharma P, Dash N, et al. Extension of hepatic metastatic tumor along a biliary drainage catheter tract: Case report. Cardiovasc Intervent Radiol 1987; 10: 303–304.
 
8. Takasan H, Kitamura O, Ozawa K, et al. Metastatic cancer of the liver resulting in obstruction of the extrahepatic bile duct. Am J Surg 1973; 125: 782–785.
 
9. Warshaw AL, Welch JP. Extrahepatic biliary obstruction by metastatic colon carcinoma. Ann Surg 1978; 188: 593–597.
 
10. Maroy B, Moullot P, Daloubeix H, et al. Intraductal biliary metastasis of a colonic cancer [in French]. Ann Radiol (Paris) 1988; 31: 309–311.
 
11. Stanley JH, Yantis PL, Marsh WH. Periportal tuberculous adenitis: A rare cause of obstructive jaundice. Gastrointest Radiol 1984; 9: 227–229.
 
12. Caroli-Bosc FX, Conio M, Maes B, et al. Abdominal tuberculosis involving hepatic hilar lymph nodes: A cause of portal vein thrombosis and portal hypertension. J Clin Gastroenterol 1997; 25: 541–543.
 
13. Markowitz SM, Kerkering TM, Gervin AS. Biliary obstruction and cholestasis in AIDS: Case report. Va Med 1990; 117: 114–116.
 
14. Sung MW, Bruckner HW, Szabo S, et al. Extrahepatic obstructive jaundice due to colorectal cancer. Am J Gastroenterol 1988; 83: 267–270.
 
15. Levine AW, Donegan WL, Irwin M. Adenocarcinoma of the colon with hepatic metastases: Fifteen-year survival. JAMA 1982; 247: 2809–2810.
 
16. Roslyn JJ, Kuchenbecker S, Longmire WP, et al. Floating tumor debris: A cause of intermittent biliary obstruction. Arch Surg 1984; 119: 1312–1315.
 
17. Iwasaki M, Furuse J, Yoshino M, et al. Percutaneous transhepatic biliary drainage for the treatment of obstructive jaundice caused by metastases from nonbiliary and nonpancreatic cancers. Jpn J Clin Oncol 1996; 26: 465–468.
 
18. Nelsen KM, Kastan DJ, Shetty PC, et al. Utilization pattern and efficacy of nonsurgical techniques to establish drainage for high biliary obstruction. J Vasc Interv Radiol 1996; 7: 751–756.
 
19. Benchimol S, Fuks A, Jothy S, et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989; 57: 327–334.
 
20. Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer 1995; 31A: 1207–1209.
 
21. Gervaz P, Blanchard A, Pampallona S, et al. Prognostic value of postoperative carcinoembryonic antigen concentration and extent of invasion of resection margins after hepatic resection for colorectal metastases. Eur J Surg 2000; 166: 557–561.
 
22. Zheng CX, Zhan WH, Zhao JZ, et al. The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol 2001; 7: 431–434.
 
23. Harned RK II, Chezmar JL, Nelson RC. Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: Location and time of discovery as determined by CT. AJR Am J Roentgenol 1994; 163: 93–97.
 
24. Noura S, Yamamoto H, Ohnishi T, et al. Comparative detection of lymph node micrometastases of Stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002; 20: 4232–4241.
 
25. Guller U, Zajac P, Schnider A, et al. Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002; 236: 768–776.
 
26. McPherson SJ, Gibson RN, Collier NA, et al. Percutaneous transjejunal biliary intervention: 10-year experience with access via Roux-en-Y loops. Radiology 1998; 206: 665–672.
 
27. An ZY, Reed WD. Placement of stent for bile drainage by using combined percutaneous and endoscopic technique [in Chinese]. Zhonghua Nei Ke Za Zhi 1994; 33: 379–381.
 
28. Dixon JM, Armstrong CP, Duffy SW, et al. Factors affecting morbidity and mortality after surgery for obstructive jaundice: A review of 373 patients. Gut 1983; 24: 845–852.
 
29. Blamey SL, Fearon KC, Gilmour WH, et al. Prediction of risk in biliary surgery. Br J Surg 1983; 70: 535–538.
 
30. Men S, Hekimoglu B, Kaderoglu H, et al. Palliation of malignant obstructive jaundice: Use of self-expandable metal stents. Acta Radiol 1996; 37: 259–266.
 
31. Besser P. Percutaneous treatment of malignant bile duct strictures in patients treated unsuccessfully with ERCP. Med Sci Monit 2001; 7 (Suppl 1): 120–122.
 
32. Koven IH, Steinhardt MI, Reichstein B. Percutaneous antegrade biliary drainage: A nonoperative approach to biliary obstruction. Can J Surg 1981; 24: 591–593.
 
33. Ducreux M, Liguory C, Lefebvre JF, et al. Management of malignant hilar biliary obstruction by endoscopy: Results and prognostic factors. Dig Dis Sci 1992; 37: 778–783.
 
34. Molnar W, Stockum AE. Relief of obstructive jaundice through percutaneous transhepatic catheter: A new therapeutic method. Am J Roentgenol Radium Ther Nucl Med 1974; 122: 356–367.
 
35. Joseph PK, Bizer LS, Sprayregen SS, et al. Percutaneous transhepatic biliary drainage: Results and complications in 81 patients. JAMA 1986; 255: 2763–2767.
 
36. Thomas JH, Pierce GE, Karlin C, et al. Extrahepatic biliary obstruction secondary to metastatic cancer. Am J Surg 1981; 142: 770–773.
 
37. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985; 55: 1284–1290.